Sylvester Comprehensive Cancer Center ASCO Review 2018

OVERVIEW

This educational activity will provide participants with an overview of the most up-to-date research and clinical advances in the treatment of various oncologic malignancies, based on abstracts presented at the June 2018 annual meeting of the American Society of Clinical Oncology (ASCO). The presentations will guide the clinicians’ continuing education through clinical knowledge, structured feedback to improve clinical decision-making and patient management. It will provide clinicians with an opportunity to discuss their opinions on the latest research findings and identify strategies to improve their practice. This conference will also serve as a teaching opportunity enabling the presenters to share their professional knowledge and experience.

TARGET AUDIENCE

This educational activity is intended for medical oncologists, and radiation oncologists, as well as physician assistants, nurses, nurse practitioners and trainees in these disciplines engaged in the care of oncology patients and will include discussions of new standards-of-care therapies based on the most recent clinical research findings presented at ASCO.

LEARNING OBJECTIVES

The intended result of this activity is increased knowledge, competence, performance and skill, and enhanced patient care. At the conclusion of this activity, participants will be able to:

  • Summarize recent and emerging data from key studies in clinical and translational cancer research for the following areas: lymphoma/hematological malignancies, breast cancer, genitourinary cancer, gastrointestinal tract cancer, lung cancer, head and neck cancers, melanoma and sarcomas.
  • Implement strategies designed to improve the quality of cancer care, address barriers to optimal care and enhance the patient experience.
  • Include new evidence as appropriate when developing innovative clinical strategies to improve patient outcomes.
  • Identify scientific advances that further enhance knowledge of cancer biology and pathogenesis

CREDIT DESIGNATION

The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACCREDITATION

The University of Miami Leonard M. Miller School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

DISCLOSURE AND CONFLICT OF INTEREST RESOLUTION

All conflicts of interest of any individual(s) in a position to control the content of this CME activity will be identified and resolved prior to this educational activity being provided. Disclosure about provider and faculty relationships, or the lack thereof, will be provided to learners.

Learn More & Register Here

© 2021 FLASCO | Premium Website Design by The HDG

FLASCO